Evrys was interested in expanding its product pipeline and and in receiving non-dilutive funding from the Department of Defense (DoD) and other Federal Agencies to supplement their NIH-funded research.
Evrys was aware of medical countermeasures (MCM) as an option to pursue; however, the team required guidance to efficiently navigate the DoD/Federal Agency funding and resources to accelerate these processes.
This client asked us to assist her team in pursuing non-dilutive funding to accelerate the discovery and development of her company’s broad-spectrum antiviral therapeutic platform.
In addition, she wanted to expand from NIH-funded research to Department of Defense (DoD) and other Federal Agencies. This was a significant pipeline expansion project, but our Client knew what was required and trusted us to get them there.
- Develop Strategic Roadmap
- Pursue Non-Dilutive Funding Projects
- Establish DoD Collaboration and Communications